| scholarly article | Q13442814 |
| P2093 | author name string | British Committee for Standards in Haematology General Haematology Task Force | |
| P2860 | cites work | Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen | Q24655614 |
| Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura. | Q30328381 | ||
| The nontreatment of childhood ITP (or "the art of medicine consists of amusing the patient until nature cures the disease"). | Q30482201 | ||
| Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura | Q31828491 | ||
| A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura | Q33328229 | ||
| The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts | Q33332742 | ||
| Oral cyclic megadose methylprednisolone therapy for chronic immune thrombocytopenic purpura in childhood | Q33333190 | ||
| Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration | Q33334650 | ||
| The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment | Q33334937 | ||
| Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP. | Q33336010 | ||
| Idiopathic thrombocytopenic purpura and MMR vaccine | Q33336096 | ||
| Morbidity and mortality in adults with idiopathic thrombocytopenic purpura | Q33336935 | ||
| The management of isolated thrombocytopenia in Chinese adults: does bone marrow examination have a role at presentation? | Q33336993 | ||
| Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany | Q33338088 | ||
| Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy | Q33338287 | ||
| Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. | Q33338442 | ||
| The effect of treatment with Campath-1H in patients with autoimmune cytopenias | Q33339027 | ||
| Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura | Q33341062 | ||
| Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura | Q33342555 | ||
| Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura | Q33343366 | ||
| Continuing controversy in alloimmune thrombocytopenia: fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia | Q33398983 | ||
| Thrombocytopenia at delivery: a prospective survey of 6715 deliveries | Q33404459 | ||
| Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women | Q33437909 | ||
| The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura | Q33448293 | ||
| Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura | Q33450455 | ||
| Splenectomy in childhood: A review of 1413 cases | Q33468273 | ||
| Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. | Q33489560 | ||
| Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura | Q33490358 | ||
| Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura | Q33490612 | ||
| Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura | Q33490858 | ||
| Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy | Q33492656 | ||
| Fetal thrombocytopenia and its relation to maternal thrombocytopenia | Q33494198 | ||
| Combination chemotherapy in refractory immune thrombocytopenic purpura | Q33494593 | ||
| Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders | Q33495801 | ||
| Diagnosis, treatment and pathophysiology of autoimmune thrombocytopenias | Q33496548 | ||
| High-dose dexamethasone therapy in chronic idiopathic thrombocytopenic purpura | Q33497479 | ||
| Therapy for adults with refractory chronic immune thrombocytopenic purpura | Q33498485 | ||
| High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura | Q33499302 | ||
| Autoimmune (idiopathic) thrombocytopenic purpura. | Q33499391 | ||
| Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group | Q33499653 | ||
| Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines | Q33500233 | ||
| Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. | Q33500729 | ||
| Reticulated platelet counts in the diagnosis of acute immune thrombocytopenic purpura | Q33501771 | ||
| Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit | Q33501809 | ||
| Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? | Q33502241 | ||
| Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: report of seven patients and a meta-analysis | Q33502293 | ||
| Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia | Q33505116 | ||
| Mycophenolate mofetil and its mechanisms of action | Q33957177 | ||
| Long-term management after splenectomy. Lifelong penicillin unproved in trials... | Q42559657 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| autoimmune thrombocytopenic purpura | Q638729 | ||
| P304 | page(s) | 574-596 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy | |
| P478 | volume | 120 |
| Q33437824 | A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia. |
| Q33428526 | A Case Report of an Elderly Woman With Thrombocytopenia and Bilateral Lung Infiltrates: A Rare Association Between Diffuse Alveolar Hemorrhage and Idiopathic Thrombocytopenic Purpura |
| Q33392044 | A Case of HELLP Syndrome in a Patient with Immune Thrombocytopenic Purpura |
| Q88256691 | A Randomized Multicenter Trial Comparing Low-Dose Prednisolone Versus Observation for Prevention of Recurrences in Adult Immune Thrombocytopenia |
| Q33379740 | A case report of the Modified Malmö Protocol: an alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura |
| Q33415432 | A cost-effectiveness study of intravenous immunoglobulin in childhood idiopathic thrombocytopenia purpura patients with life-threatening bleeding |
| Q45878189 | A diagnostic dilemma: variant Bernard-Soulier syndrome, a difficult clinical and genetic diagnosis |
| Q33435295 | A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias |
| Q38215441 | A novel method for laparoscopic splenectomy in the setting of hypersplenism secondary to liver cirrhosis: ten years' experience |
| Q33385082 | A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura |
| Q33392093 | A retrospective analysis of obstetric patients with idiopathic thrombocytopenic purpura: a single center study |
| Q36654370 | A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. |
| Q33414825 | A review of the management of childhood immune thrombocytopenia: how can we provide an evidence-based approach? |
| Q33358032 | Adult idiopathic thrombocytopenic purpura |
| Q28742871 | Advances in ITP--therapy and quality of life--a patient survey |
| Q84156696 | An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases |
| Q33373074 | An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura |
| Q33400275 | An unusual haematological presentation of the immune reconstitution inflammatory syndrome |
| Q33433571 | Anaesthesia for Caesarean Section of Pregnant Women with Idiopathic Thrombocytopenic Purpura |
| Q37843939 | Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders. |
| Q33379770 | Antiphospholipid antibodies in adults with immune thrombocytopenic purpura |
| Q33409515 | Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding. |
| Q40537984 | Aplastic anemia associated with pregnancy: maternal and fetal complications |
| Q33395789 | Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population |
| Q33397553 | Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP). |
| Q92923519 | Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs |
| Q33395141 | Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment |
| Q90722822 | Autoimmune cytopenias and thrombotic thrombocytopenic purpura |
| Q33411345 | Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects |
| Q33367861 | Autoimmune thrombocytopenia |
| Q33381985 | BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura |
| Q35770266 | Best practice in primary care pathology: review 3 |
| Q42581063 | Cerebral infarction in idiopathic thrombocytopenic purpura: a case report |
| Q92998865 | Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study |
| Q30808680 | Childhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic Purpura |
| Q27023294 | Childhood immune thrombocytopenia: Clinical presentation and management |
| Q52605697 | Chinese guidelines for treatment of adult primary immune thrombocytopenia. |
| Q33434365 | Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist |
| Q33366005 | Chronic refractory ITP in children: beyond splenectomy |
| Q57822987 | Clinical features and outcome in paediatric newly diagnosed immune thrombocytopenic purpura in a tertiary care centre |
| Q33417352 | Clinical features of gestational thrombocytopenia difficult to differentiate from immune thrombocytopenia diagnosed during pregnancy |
| Q33398637 | Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura |
| Q21328697 | Comorbidities of idiopathic thrombocytopenic purpura: a population-based study |
| Q33395014 | Comparison of conventional dose steroid treatment and high dose steroid treatment as run-in regime for splenectomy in immune thrombocytopenic purpura (ITP). |
| Q33373425 | Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia |
| Q33406792 | Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods |
| Q33370088 | Consensus guideline for diagnosis and treatment of childhood idiopathic thrombocytopenic purpura |
| Q33431036 | Consensus of Chinese experts on diagnosis and treatment of adult primary immune thrombocytopenia (version 2016) |
| Q39558396 | Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use. |
| Q33375829 | Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura |
| Q33379882 | Cost-effectiveness of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)--a systematic review |
| Q33392179 | Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis |
| Q33393474 | Determination of platelet-bound glycoprotein-specific autoantibodies by flow cytometric immunobead assay in primary immune thrombocytopenia |
| Q33433610 | Diagnostic predictive value of platelet indices for discriminating hypo productive versus immune thrombocytopenia purpura in patients attending a tertiary care teaching hospital in Addis Ababa, Ethiopia. |
| Q24674173 | Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity? |
| Q33400296 | Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort |
| Q44895516 | Effectiveness of Helicobacter pylori eradication in pregnant women with idiopathic thrombocytopenic purpura. |
| Q92556653 | Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q33439371 | Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia |
| Q33385549 | Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura |
| Q33391987 | Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia |
| Q33386764 | Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia |
| Q33381879 | Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. |
| Q44988721 | Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients |
| Q33375988 | Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura |
| Q33426717 | Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy |
| Q33419309 | Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia |
| Q33366703 | Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study |
| Q42547430 | Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura |
| Q33391229 | Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations |
| Q33426819 | Eltrombopag enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpura |
| Q33391580 | Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study |
| Q33438414 | Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation |
| Q33416582 | Eltrombopag for resistant immune thrombocytopenia secondary to chronic lymphocytic leukaemia |
| Q33428571 | Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study |
| Q33384108 | Eltrombopag. |
| Q33400722 | Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia |
| Q33382754 | Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura |
| Q50098870 | Episode of Kasabach-Merritt phenomenon following Japanese encephalitis vaccination: Case report |
| Q33357291 | Evaluation and management of childhood idiopathic (immune) thrombocytopenia |
| Q33419925 | Evaluation of 143 cases of immune thrombocytopenic purpura with regards to clinical course and response to treatment |
| Q33413901 | Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia |
| Q33394156 | Fatigue in adult patients with primary immune thrombocytopenia |
| Q33388868 | Genetic studies in pediatric ITP: outlook, feasibility, and requirements |
| Q92686593 | Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia |
| Q33402328 | H pylori-induced thrombocytopenia in a Caucasian female: a case report |
| Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
| Q33402242 | Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States |
| Q33374847 | Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China |
| Q26865062 | Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography |
| Q33373338 | Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies |
| Q33369972 | Helicobacter pylori-associated immune thrombocytopenia |
| Q33417972 | Hematologic manifestations of Helicobacter pylori infection |
| Q33421032 | Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India |
| Q33428115 | High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up |
| Q33388561 | High dose dexamethasone therapy shows better responses in acute immune thrombocytopenia than in chronic immune thrombocytopenia |
| Q33386471 | High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura |
| Q33431371 | How we manage immune thrombocytopenia in the elderly |
| Q33433460 | Hypomegakaryocytic thrombocytopenia (HMT): an immune-mediated bone marrow failure characterized by an increased number of PNH-phenotype cells and high plasma thrombopoietin levels |
| Q33369925 | Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. |
| Q33380751 | Idiopathic thrombocytopenic purpura in childhood: a 10-year audit |
| Q33378924 | IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions |
| Q38842992 | Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity |
| Q79097533 | Immune or idiopathic thrombocytopenic purpura (ITP) in childhood: what are the risks and who should be treated? |
| Q33434971 | Immune thrombocytopenia and pregnancy |
| Q33387170 | Immune thrombocytopenia in pregnancy |
| Q33395624 | Immune thrombocytopenia: no longer 'idiopathic'. |
| Q81808242 | Immune thrombocytopenic purpura |
| Q33418883 | Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases |
| Q33363927 | Immune thrombocytopenic purpura - current management practices |
| Q91292126 | Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study |
| Q52648393 | Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy. |
| Q33404315 | Immune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions |
| Q35102141 | Indications for IVIG in rheumatic diseases |
| Q38009892 | Inherited platelet disorders and oral health. |
| Q33356945 | Intravenous anti‐D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy |
| Q33383108 | Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura |
| Q53224288 | Is flow cytometry accurate enough to screen platelet autoantibodies? |
| Q33415342 | Is incidental gestational thrombocytopaenia really always safe for the neonate? |
| Q33374986 | Is it safe to avoid bone marrow examination in suspected itp? |
| Q37417311 | Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. |
| Q28066579 | Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges |
| Q33421755 | Late results after splenectomy in adult idiopathic thrombocytopenic purpura |
| Q33439137 | Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012. |
| Q60304458 | Life-threating outcomes after dental implantation in patient with idiopathic thrombocytopenic purpura: a case report and review of literature |
| Q33396196 | Long-term outcome of isolated thrombocytopenia accompanied by hypocellular marrow |
| Q33393057 | Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy |
| Q33408915 | Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study |
| Q33378160 | Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience |
| Q33402387 | Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions |
| Q33403726 | Management of immune thrombocytopenic purpura: an update |
| Q33372113 | Management of patients with refractory immune thrombocytopenic purpura |
| Q24240471 | Medical treatments for idiopathic thrombocytopenic purpura during pregnancy |
| Q24240685 | Medical treatments for idiopathic thrombocytopenic purpura during pregnancy |
| Q88048002 | Modeling and Simulation Support Eltrombopag Dosing in Pediatric Patients With Immune Thrombocytopenia |
| Q33430385 | Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines |
| Q33393187 | Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults |
| Q33387735 | New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents. |
| Q33377901 | New insights and therapeutics for immune-mediated thrombocytopenia |
| Q33383894 | New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura |
| Q33396931 | Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group |
| Q33408491 | Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. |
| Q33426482 | Outcomes of total hip arthroplasty in patients with primary immune thrombocytopenia |
| Q35186288 | Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: a case report |
| Q33383468 | Pathobiology of secondary immune thrombocytopenia |
| Q33392868 | Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters |
| Q33393732 | Pathophysiology and therapeutic options in primary immune thrombocytopenia |
| Q33400348 | Patient-reported treatment burden of chronic immune thrombocytopenia therapies |
| Q33388078 | Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies |
| Q38695888 | Patterns of care and burden of chronic idiopathic thrombocytopenic purpura in Brazil |
| Q37089075 | Perinatal Management for a Pregnant Woman with an MYH9 Disorder |
| Q33403464 | Perinatal outcome of pregnancies complicated by immune thrombocytopenia. |
| Q33386999 | Perinatal outcomes and complications of pregnancy in women with immune thrombocytopenic purpura |
| Q41763490 | Perioperative care of a patient with refractory idiopathic thrombocytopenic purpura undergoing total knee arthroplasty |
| Q98775601 | Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial |
| Q64913128 | Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia. |
| Q33375925 | Pitfalls in the diagnosis of immune thrombocytopenic purpura in children: 4 case reports |
| Q90402232 | Plasma levels and expression of interleukin-37 in patients with immune thrombocytopenia |
| Q33402843 | Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists |
| Q33416254 | Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders |
| Q33365129 | Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia |
| Q47405698 | Platelet transfusions in haematology patients: are we using them appropriately? |
| Q33419774 | Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality |
| Q33373952 | Predictors of idiopathic thrombocytopenic purpura in pregnant women presenting with thrombocytopenia |
| Q38632350 | Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. |
| Q33409077 | Pregnancy outcome in patients with idiopathic thrombocytopenic purpura |
| Q33372582 | Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study |
| Q33402397 | Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre. |
| Q33398568 | Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom |
| Q33400018 | Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO) |
| Q91992501 | Proposal of treatment algorithm for immune thromocytopenia in adult patients of a hematology service at a referral center in Northeastern Brazil |
| Q33403688 | Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia |
| Q33365386 | Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura |
| Q40066935 | Recent trends in practice patterns and comparisons between immunoglobulin and corticosteroid in pediatric immune thrombocytopenia |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q33429418 | Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy |
| Q33357961 | Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options |
| Q33396342 | Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura |
| Q33405057 | Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP). |
| Q33362304 | Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism. |
| Q33370711 | Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura |
| Q33374085 | Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation |
| Q33384996 | Review article: second-generation thrombopoietin agents for treatment of chronic idiopathic thrombocytopenic purpura in adults |
| Q33416359 | Rituximab efficacy in the treatment of children with chronic immune thrombocytopenic purpura |
| Q33400324 | Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura |
| Q33384267 | Romiplostim management of immune thrombocytopenic purpura |
| Q28539282 | Safety and efficacy of Gammaplex® in idiopathic thrombocytopenic purpura (ClinicalTrials.gov--NCT00504075) |
| Q33436552 | Safety and efficacy of a 10% intravenous immunoglobulin preparation in patients with immune thrombocytopenic purpura: results of two international, multicenter studies |
| Q33414909 | Severe Case of Autoimmune Thrombocytopenia First Diagnosed in Pregnancy |
| Q33380732 | Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura |
| Q33389893 | Severe thrombocytopenia secondary to tubercular lymphadenitis |
| Q38042716 | Short- and long-term effects of exposure to natural and synthetic glucocorticoids during development |
| Q33401130 | Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? |
| Q33391871 | Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate |
| Q33414558 | Should we routinely transfuse platelet for immune thrombocytopenia patients with platelet count less than 10 × 10⁹/L who underwent laparoscopic splenectomy? |
| Q33420027 | Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients |
| Q33396799 | Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids |
| Q43171567 | Slow responses to standard dose rituximab in immune thrombocytopenic purpura |
| Q33412260 | Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura |
| Q33369981 | Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China |
| Q33368946 | Splenectomy for severe autoimmune cytopenias after allogenic stem cell transplantation: case report |
| Q33369401 | Splenectomy in haematology--a 5-year single centre experience |
| Q33407632 | Standardized clinical assessment and management plans (SCAMPs): perspectives on a new method to understand treatment decisions and outcomes in immune thrombocytopenia |
| Q33393440 | Subdural haematoma in pregnancy-induced idiopathic thrombocytopenia: Conservative management |
| Q33409999 | Successful perioperative management of a patient with idiopathic thrombocytopenic purpura undergoing emergent appendectomy: Report of a case |
| Q33421663 | Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults |
| Q24235481 | TPO receptor agonist for chronic idiopathic thrombocytopenic purpura |
| Q24241275 | TPO receptor agonist for chronic idiopathic thrombocytopenic purpura |
| Q41487980 | The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach |
| Q33428522 | The Effect of Danazol in Primary Immune Thrombocytopenia: An Analysis of a Large Cohort From a Single Center in China |
| Q33440074 | The Efficacy of Colchicine and Dapsone Combination Therapy in Relapsed Immune Thrombocytopenia |
| Q27694559 | The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use |
| Q33384235 | The ITP syndrome: pathogenic and clinical diversity |
| Q40270719 | The Use of Plasmapheresis in Patients with Bronchiectasis with Pseudomonas aeruginosa Infection and Inhibitory Antibodies |
| Q90700097 | The association of hyperthyroidism and immune thrombocytopenia: Are we still missing something? |
| Q33393050 | The diagnostic utility of bone marrow biopsies performed for the investigation of fever and/or cytopenias in HIV-infected adults at Groote Schuur Hospital, Western Cape, South Africa |
| Q33407279 | The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia |
| Q33394796 | The experience of Flebogammadif® in primary immune thrombocytopenia |
| Q33428804 | The management of immune thrombocytopenic purpura |
| Q33412330 | Therapeutic Options for Immune Thrombocytopenia (ITP) During Pregnancy |
| Q30240119 | Thrombocytopenia and infections |
| Q33443791 | Thrombocytopenia in pregnancy with different diagnoses: Differential clinical features, treatments, and outcomes |
| Q31112245 | Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
| Q33429138 | Thrombocytopenia: diagnosis with flow cytometry and antiplatelet antibodies |
| Q33384884 | Thrombocytopenias: a clinical point of view |
| Q33388213 | Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database |
| Q30250259 | Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis |
| Q35612588 | Total Hip Arthroplasty for Rapidly Destructive Coxarthrosis in a Patient with Severe Platelet Deficiency due to Liver Cirrhosis and Immune Thrombocytopenic Purpura |
| Q33432920 | Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim |
| Q33393111 | Treatment of idiopathic thrombocytopenic purpura in pregnancy with pulsed dose of dexamethasone |
| Q30351606 | Treatment of immune thrombocytopenic purpura in children : current concepts. |
| Q33431840 | Treatment of patients with immune thrombocytopenia admitted to the emergency room |
| Q36458599 | Unique donor-suitability issues |
| Q42361533 | Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? |
| Q33405328 | Vaccine administration and the development of immune thrombocytopenic purpura in children |
| Q89550076 | [How I treat primary immune thrombocytopenia in pregnancy] |
| Q52650267 | [The efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia]. |
Search more.